当前位置:主页 > 经济论文 > 产业经济论文 >

基于开放式创新的云南生物制药产业产学研合作机制与模式研究

发布时间:2018-09-07 18:02
【摘要】:在全球化、信息化的背景下,随着生物科学技术的不断进步,生物制药产业经历了从孕育、结网、成长到发展的过程,逐步从“封闭式”创新的发展模式向“开方式”创新的发展模式转变。作为开放式创新活动的实践,产学研合作创新逐渐得到了产业界、学术界和政府的高度重视,对于提高企业的自主创新能力与产业竞争能力都产生了巨大的作用。生物制药产业作为云南省的战略性新兴产业,近几年已取得了蓬勃的发展,但从整个产业来看,云南生物制药产业的技术创新模式仍是封闭的,利用外部资源的能力十分有限,制药商与供应商的关系并非是开放式创新环境下的合作关系,而是保持着一种传统的买卖关系,同时,企业、高校和科研机构在文化认同、社会职责方面存在差异,使得产学研合作创新实践中的机制与模式的构建并不完善,加之技术创新的成果并不适应市场的需求,产业化水平比较低,使得当前产学研合作的成功率较低且效率低下。因此,本文以开放式创新为视角,综合运用文献研究法、比较研究法、案例研究法和博弈论研究方法,以云南白药集团股份有限公司为案例开展研究工作。首先,对国内外开放式创新和产学研合作的研究现状进行有针对性的回顾与评述;然后,在对云南生物制药产业发展现状进行深入调查的基础上,对云南生物制药产业产学研合作的现状进行分析并指出存在的问题;接着,针对目前云南生物制药产业产学研合作存在的问题,构建具有代表性的云南生物制药产业产学研合作机制,分析云南生物制药产业产学研合作的主要模式,建立云南生物制药企业产学研合作创新的选择博弈模型,并以云南白药集团为案例,使理论与实践相结合;最后,按照所提出的产学研合作机制与模式,提出对云南生物制药产业产学研合作创新的对策与措施,为云南省政府、发改委等管理部门制定云南生物制药产业的产学研合作政策提供理论依据,以及具有可操作性的对策建议和措施。
[Abstract]:Under the background of globalization and informatization, with the continuous progress of biological science and technology, the biopharmaceutical industry has experienced a process from gestation, networking, growth to development. Gradually from the "closed" innovative development model to "open" innovative development model. As the practice of open innovation activities, industry-university-research cooperative innovation has gradually been attached great importance to by industry, academia and government, which has played a great role in improving the independent innovation ability and industrial competition ability of enterprises. As a strategic emerging industry in Yunnan Province, the biopharmaceutical industry has made vigorous development in recent years. However, from the perspective of the whole industry, the technological innovation mode of Yunnan biopharmaceutical industry is still closed, and its ability to utilize external resources is very limited. The relationship between pharmaceutical manufacturers and suppliers is not a cooperative relationship in an open innovation environment, but a traditional trading relationship. At the same time, there are differences in cultural identity and social responsibilities among enterprises, universities and scientific research institutions. It makes the construction of the mechanism and model in the practice of cooperation innovation of industry, college and research not perfect, and the achievements of technology innovation do not meet the needs of the market, and the industrialization level is relatively low, which makes the success rate and efficiency of the cooperation between industry, college and research low. Therefore, from the perspective of open innovation, this paper makes use of literature research method, comparative research method, case study method and game theory research method, and takes Yunnan Baiyao Group Co., Ltd as a case study. First of all, the research status of open innovation and industry-university-research cooperation at home and abroad is reviewed and reviewed, and then, on the basis of in-depth investigation of the current situation of bio-pharmaceutical industry in Yunnan, This paper analyzes the present situation of Yunnan Biopharmaceutical Industry, and points out the existing problems, and then, aiming at the existing problems of Yunnan Biopharmaceutical Industry, Constructing the representative cooperation mechanism of Yunnan biopharmaceutical industry, analyzing the main mode of Yunnan biopharmaceutical industry cooperation, and establishing the selection game model of Yunnan biopharmaceutical enterprises' cooperation innovation. Taking Yunnan Baiyao Group as an example, the theory and practice are combined. Finally, according to the proposed cooperation mechanism and mode of industry-university-research, the countermeasures and measures for the cooperation and innovation of Yunnan Biopharmaceutical Industry are put forward for the Yunnan Provincial Government. Development and Reform Commission and other administrative departments to formulate the Yunnan Biopharmaceutical Industry cooperation policy to provide theoretical basis, as well as operable countermeasures and measures.
【学位授予单位】:昆明理工大学
【学位级别】:硕士
【学位授予年份】:2016
【分类号】:F426.72

【相似文献】

相关期刊论文 前10条

1 刘霜桂;台湾将中草药列入生物制药产业重点[J];台湾农业探索;2001年01期

2 晏铃;积极采用风险投资促进我省生物制药产业发展[J];云南财贸学院学报;2001年02期

3 ;国家级生物制药产业基地落户南海[J];中国药房;2003年12期

4 ;国家级生物制药产业基地落户南海[J];中国医院用药评价与分析;2003年06期

5 江涛;;生物制药产业热盼盈利[J];新经济导刊;2003年06期

6 白远 ,罗风基;北京市生物制药产业国际竞争力研究[J];国际经济合作;2004年05期

7 ;我国生物制药产业发展方向[J];中国药科大学学报;2005年06期

8 王申;;我国生物制药产业的发展分析[J];企业研究;2008年06期

9 李玉彬;钱晓璐;;生物制药产业发展现状与趋势[J];现代农业科技;2010年15期

10 洪进;余文涛;汪凯;;基于“行动者网络理论”的中国生物制药产业技术的演化和治理研究[J];中国科技论坛;2010年11期

相关会议论文 前8条

1 吴梧桐;王友同;吴文俊;;持续快速发展的生物制药产业[A];华东六省一市生物化学与分子生物学会2010年学术交流会论文集[C];2010年

2 董丽;唐亚军;宋娟;;对加强我国生物制药产业监管的几点建议[A];2009年中国药学会药事管理专业委员会年会暨“国家药物政策与《药品管理法》修订研究”论坛论文文集[C];2009年

3 柳卸林;;中国能创新吗?以生物制药产业为例[A];首届中国科技政策与管理学术研讨会2005年论文集(上)[C];2005年

4 王英晓;许q,

本文编号:2229010


资料下载
论文发表

本文链接:https://www.wllwen.com/jingjilunwen/chanyejingjilunwen/2229010.html


Copyright(c)文论论文网All Rights Reserved | 网站地图 |

版权申明:资料由用户a5a48***提供,本站仅收录摘要或目录,作者需要删除请E-mail邮箱bigeng88@qq.com